§ 40-43-200 — Joint Pharmacist Administered Vaccines Committee; meetings, quorum, and chairperson; duties of committee.

(A) There is created a Joint Pharmacist Administered Vaccines Committee as a committee to the Board of Medical Examiners which consists of seven members. The committee is comprised of two physicians selected by the Board of Medical Examiners, two pharmacists selected by the Board of Pharmacy, and two advanced practice nurse practitioners selected by the Board of Nursing. One member of the Department of Health and Environmental Control designated by the director of the department also shall serve on the committee. Members of the committee may not be compensated for their service on the board and may not receive mileage, per diem, and subsistence as otherwise authorized by law for members of state boards, committees, and commissions. (B) The committee shall meet at least once annually and at other times as may be necessary. Five members constitute a quorum for all meetings. At its initial meeting, and at the beginning of each year thereafter, the committee shall elect from its membership a chairperson to serve for a one-year term. (C) The committee shall assist and advise the Board of Medical Examiners in determining whether a specific vaccine is appropriate for administration by a pharmacist without a written order or prescription of a practitioner pursuant to Section 40-43-190. For a specific vaccine recommended by the committee to the Board of Medical Examiners, the committee also must submit a proposed written protocol for the purpose of authorizing pharmacists to administer the vaccine.

Legislative History

HISTORY: 2010 Act No. 224, SECTION 1, eff July 1, 2010; 2015 Act No. 29 (S.413), SECTION 2, eff June 1, 2015; 2024 Act No. 221 (H.3988), SECTION 6, eff July 2, 2024. Editor's Note 2024 Act No. 221, SECTION 7, provides as follows: "SECTION 7. The Joint Pharmacist Administered Vaccines Committee must submit its initial recommendations to the board no later than four months after the passage of this act, and periodically thereafter as determined by the committee." Effect of Amendment 2015 Act No. 29, SECTION 2, in (A), substituted "Joint Pharmacist Administered Vaccines Committee" for "Joint Pharmacist Administered Influenza Vaccines Committee", deleted "influenza" before "vaccines" at the end of the first sentence, and substituted "director" for "commissioner" in the third sentence; and rewrote (C). 2024 Act No. 221, SECTION 6, in (A), in the first sentence, deleted "with experience regarding vaccines" at the end; in (C), in the second sentence, deleted "as authorized by Section 40-43-190" at the end and deleted the third sentence, which provided that the committee must submit its initial recommendations to the board no later than four months after the passage of this act, and periodically thereafter as determined by the committee; and made a nonsubstantive change.